Skip to main content

Table 4 Clinical characteristics of the EGFR wild type group

From: Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

 

Responsive

Resistance

Group

Group

Gender

  

 Male

6

13

 Female

18

11

Age

  

 Median

62

58

Smoking

  

 Yes

6

9

 No

18

15

Pathology

  

 Ade

21

18

 Non-ade

3

6

Stage

  

 IIIB

4

7

 IV

20

17

Median PFS(months)

17.1(14.8-51.3)

2.1 (0.3-3.5)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us